Search results
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 3 days agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
‘What do we do?’ CommonSpirit hospitals no longer in-network for thousands of Coloradans with Anthem...
Summit Daily News· 6 days agoSummit County resident Lisa Fine says she loves the primary care doctor and specialists she’s seen...
Amgen (NASDAQ:AMGN) Price Target Cut to $328.00
ETF DAILY NEWS· 3 days agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target reduced by Royal Bank of Canada from $332.00 to $328.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently ...
Study Explores Controversial Hormone Therapy for Menopause—With Surprising Results
Prevention· 7 days agoA follow-up study to the Women’s Health Initiative finds that hormone replacement therapy is...
Science shorts: Benefits of EPA for migraine, vitamin D in reducing menstrual pain and more
Nutraingredients.com· 5 days agoTaking 1,800mg of omega-3 eicosapentaenoic acid (EPA) daily has significantly reduced migraine...
Me, Myself, as Mommy: Menopause journey exposes the limitations of women’s health care
Standard-Examiner· 5 days agoIt was when hot flashes were introduced to the lineup that I started to consider menopause. Because...
Ligand Pharmaceuticals (LGND) to Release Quarterly Earnings on Tuesday
ETF DAILY NEWS· 2 days agoLigand Pharmaceuticals (NASDAQ:LGND – Get Free Report) will be announcing its earnings results after the market closes on Tuesday, May 7th. Ligand Pharmaceuticals has set its FY 2024 guidance ...